New Enterprise Associates 15, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

New Enterprise Associates 15, L.P. sits at the top of its group. 13 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (12 companies). Each entity in the chart links to its source.

Stakes it holds

New Enterprise Associates 15, L.P. has told the SEC it owns more than 5% of 12 companies, latest first (Schedules 13D and 13G).

• Nkarta Therapeutics (United States)SCHEDULE 13D/A May 5, 2022 to May 19, 2026²
• Arcellx, Inc.SCHEDULE 13D/A Feb 17, 2022 to Apr 30, 2026³
• Senti Biosciences Holdings, Inc.SCHEDULE 13D/A Jul 15, 2022 to Mar 31, 2026⁴
• OnKure Therapeutics, Inc.SC 13D/A May 8, 2024 to Oct 8, 2024⁵
• Desktop Metal, Inc.SC 13D/A Oct 7, 2021 to May 2, 2024⁶
• Bright HealthSC 13D/A Dec 29, 2021 to Apr 10, 2024⁷
• Inozyme Pharma, Inc.SC 13G/A Feb 7, 2022 to Feb 14, 2024⁸
• IONQSC 13D/A Oct 21, 2021 to Jun 9, 2023⁹
• Berkshire Grey, Inc.SC 13D/A Apr 10, 2023¹⁰
• Eargo, Inc.SC 13D/A Dec 12, 2022¹¹
• RobinhoodSC 13D/A Feb 9, 2022 to May 5, 2022¹²
• Annexon, Inc.SC 13G/A Nov 19, 2021¹³